Overview
GenVax Solutions is at the forefront of vaccine development, leveraging cutting-edge biotechnology to create vaccines that respond rapidly to emerging infectious diseases. Established in 2024, our proprietary platform allows for the swift design and testing of vaccines, significantly reducing the time required to bring new solutions to market. Since our inception, we have developed a promising vaccine candidate for a prevalent viral infection, showing encouraging results in preclinical trials. Our team, comprised of seasoned biotech professionals and researchers, is dedicated to addressing public health challenges by creating effective and accessible vaccines. We are seeking investment to take our project to the next level. With the rising global demand for effective vaccines, especially post-pandemic, our work is more critical than ever. The funds will directly support our ongoing clinical trials and enable us to expand our laboratory capabilities, ensuring we can not only meet current demands but also position ourselves as leaders in vaccine technology. We have already secured partnerships with several universities and healthcare organizations, demonstrating both interest and con…
Use of funds
The requested investment of $2,610,000 will be allocated as follows:
- Clinical Trials (60%): Conducting advanced clinical trials to validate safety and efficacy.
- Team Expansion (20%): Hiring experienced researchers and clinical trial managers to support growth.
- Laboratory Equipment (10%): Upgrading lab facilities with state-of-the-art technology to enhance research capabilities.
- Regulatory Compliance (10%): Ensuring all developments meet stringent regulatory requirements, facilitating smooth approvals.
Open case
Open this case to get the detailed business plan and direct contact with the founder or seeker.